OTUD4 (OTU Domain Containing 4, also known as DUBA) is a member of the OTU (ovarian tumor) family of deubiquitinating enzymes (DUBs) that plays critical roles in maintaining cellular homeostasis through protein quality control, DNA damage response, and stress adaptation [@zhang2015]. This gene has garnered significant attention in neuroscience due to its emerging roles in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD) [@schwab2018; @wang2024].
The OTUD4 protein possesses unique enzymatic properties among OTU family members. Unlike most OTU deubiquitinases that specifically cleave either K48- or K63-linked ubiquitin chains, OTUD4 demonstrates dual specificity, able to hydrolyze both chain types. This versatility allows OTUD4 to regulate diverse cellular processes, from protein degradation to signaling pathway modulation [@zhang2015].
OTUD4 (OTU Domain Containing 4, also known as DUBA) is a member of the OTU (ovarian tumor) family of deubiquitinating enzymes (DUBs) that plays critical roles in maintaining cellular homeostasis through protein quality control, DNA damage response, and stress adaptation [@zhang2015]. This gene has garnered significant attention in neuroscience due to its emerging roles in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD) [@schwab2018; @wang2024].
The OTUD4 protein possesses unique enzymatic properties among OTU family members. Unlike most OTU deubiquitinases that specifically cleave either K48- or K63-linked ubiquitin chains, OTUD4 demonstrates dual specificity, able to hydrolyze both chain types. This versatility allows OTUD4 to regulate diverse cellular processes, from protein degradation to signaling pathway modulation [@zhang2015].
<div class="infobox infobox-gene">
<table>
<tr><th>Symbol</th><td>OTUD4</td></tr>
<tr><th>Full Name</th><td>OTU Domain Containing 4</td></tr>
<tr><th>Aliases</th><td>OTUD4, DUBA, KIAA0841</td></tr>
<tr><th>Chromosomal Location</th><td>Chr4q31.3</td></tr>
<tr><th>NCBI Gene ID</th><td>54726</td></tr>
<tr><th>OMIM</th><td>611201</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000145362</td></tr>
<tr><th>UniProt ID</td><td>Q9H8M5</td></tr>
<tr><th>Protein Length</th><td>1,032 amino acids</td></tr>
<tr><th>Molecular Weight</th><td>~113 kDa</td></tr>
<tr><th>Associated Diseases</th><td>Amyotrophic lateral sclerosis, Alzheimer's disease, Neurodevelopmental disorders, Parkinson's disease</td></tr>
</table>
</div>
OTUD4 contains several distinct domains that mediate its functions:
The OTU domain (residues 264-440) contains the catalytic triad (Cys358, His418, Asp429) essential for deubiquitinase activity. Structural studies reveal that OTUD4 adopts a fold similar to other OTU enzymes but with unique insertions that confer chain type specificity [@zhang2015].
OTUD4 contains multiple C3HC4-type RING finger domains (residues 34-76, 143-186, 852-893) that facilitate protein-protein interactions and may regulate substrate recognition. These domains allow OTUD4 to function as a scaffold for multiprotein complexes [@zhang2015].
A unique region (residues 600-750) mediates interaction with GLUL (glutamate-ammonia ligase, also known as glutamine synthetase), which is crucial for OTUD4's role in glutamate metabolism regulation [@kayagaki2015].
OTUD4 contains bipartite nuclear localization signals (NLS) at residues 95-112, enabling its function in nuclear DNA repair processes.
OTUD4 catalyzes the removal of ubiquitin moieties from substrate proteins using its OTU catalytic domain. Its dual specificity (K48 and K63 linkages) distinguishes it from many other DUBs and allows fine-tuning of both proteasomal degradation and signaling pathways:
OTUD4 plays essential roles in maintaining genome integrity through regulation of DNA repair pathways:
As a DUB, OTUD4 prevents aberrant protein aggregation by:
Through stabilization of GLUL, OTUD4 directly influences glutamate recycling and ammonia detoxification in the brain. This function is particularly important given glutamate excitotoxicity's role in neurodegeneration [@kayagaki2015; @chen2019].
OTUD4 exhibits broad expression across tissues with particularly high levels in:
| Region | Expression Level | Relevance |
|--------|------------------|-----------|
| Cerebral Cortex | High | Learning, memory, executive function |
| Hippocampus | High | Memory formation, AD vulnerability |
| Basal Ganglia | Moderate-High | Motor control, PD affected |
| Cerebellum | Moderate | Motor coordination |
| Spinal Cord | High | ALS-affected region |
OTUD4 is expressed in both neurons and glia:
OTUD4 mutations were first linked to ALS in 2018 through exome sequencing studies identifying rare missense variants in patients [@schwab2018]. Pathogenic mechanisms include:
The identification of OTUD4 as an ALS gene underscores the importance of protein quality control and DNA repair in motor neuron survival.
OTUD4's involvement in AD has emerged through multiple studies:
Emerging evidence links OTUD4 to PD pathogenesis:
Biallelic OTUD4 variants cause a distinct neurodevelopmental syndrome characterized by:
OTUD4 interacts with numerous proteins involved in neurodegeneration:
| Partner | Function | Interaction Type |
|---------|----------|------------------|
| GLUL | Glutamate metabolism | Direct binding |
| p53 | Tumor suppression/DNA repair | Direct binding |
| PARP1 | DNA damage response | Direct binding |
| RAD51 | Homologous recombination | Direct binding |
| SQSTM1/p62 | Autophagy receptor | Direct binding |
| OPTN | Autophagy receptor | Direct binding |
| TBK1 | Kinase/ autophagy | Direct binding |
| TDP-43 | RNA metabolism (ALS) | Direct binding |
| tau | Microtubule (AD) | Indirect |
| alpha-synuclein | PD pathogenesis | Indirect |
OTUD4 participates in several critical cellular pathways:
Currently no selective OTUD4 inhibitors are in clinical development. However, the enzymatic activity makes it a druggable target:
OTUD4 levels in cerebrospinal fluid (CSF) may serve as a biomarker for:
OTUD4 knockout mice exhibit:
Neuron-specific OTUD4 knockout shows:
OTUD4 overexpressing mice demonstrate:
There are currently no active clinical trials specifically targeting OTUD4. However, OTUD4 modulators are being explored in preclinical settings for:
OTUD4 represents a critical node connecting protein quality control, DNA repair, and glutamate metabolism in neurodegeneration. Its dual deubiquitinase specificity and broad interactome make it a compelling therapeutic target. Understanding the precise mechanisms by which OTUD4 dysfunction contributes to ALS, AD, and PD will be essential for developing effective neuroprotective strategies.